Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 31;107(4):994–1003. doi: 10.1097/TP.0000000000004355

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

FIGURE 2. — Death-censored renal graft survival with and without prophylactic eculizumab treatment. Kaplan-Meier analysis of renal graft survival for grafts received after 2002 in recipients at medium or high risk of recurrence of atypical hemolytic uremic syndrome. Those who received prophylactic eculizumab treatment from the time of transplantation compared with those who did not receive eculizumab treatment for the duration of the transplant (control). Numbers at risk in each group at 6 monthly time points are detailed below the graph. Log-rank P = 0.006.